With 40 years of executive leadership in medical device and health care services, David serves as an independent board member and advisor to several corporations and non-profit organizations. His expertise encompasses growing highly regulated global businesses organically through R&D and innovation and inorganically through M&A, leading within a variety of foreign, public and private equity ownership structures, strategic planning, culture and talent development, succession planning, enterprise risk management, operations, compliance, and corporate governance. David retired from his leadership role at Terumo BCT in 2019, after his more than 18 years serving as President and CEO. While there, he grew the company from $160M in global revenue to $1B as an innovation-driven biomedical company focused on unlocking the potential of blood and cell-based therapies in the blood banking, transfusion medicine and cell therapy/regenerative medicine sectors. David is a member of the National Association of Corporate Directors (NACD) and serves on the boards of Ortho Clinical Diagnostics, Advanced Instruments, Laborie, Mölnlycke, Venture Capital Board, and Summit Biolabs. He also is various advisory roles at The Carlyle Group, CU Healthcare Innovation Fund, Korn Ferry Chief Executive Institute, Blackstone Entrepreneurs Network Colorado, Nurse Family Partnership, Book Trust, Fitzsimons Innovation Community at the CU Anschutz Medical Campus, Blood Centers of America, Department of Health & Human Services - Advisory Committee on Blood & Tissue Safety & Availability (ACBTSA), Centura Health St. Anthony Regional Board, and Executives Partnering to Invest in Children (EPIC).
Our mission is to be the best partner for those who save and improve patients’ lives.
Our Vision is to be the best company in health and safety sales, service and distribution.